Kaliumklorid B. Braun

Potassium Chloride, the active ingredient in Kaliumklorid B. Braun, is an electrolyte / potassium supplement presented as an intravenous solution for intravenous use. It is employed to correct hypokalemia and to provide potassium replacement in patients requiring electrolyte management. It is indicated for adult patients with documented low serum potassium levels and is commonly used in intensive care, surgery, and dialysis settings.

GNH USA supplies Kaliumklorid B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare institutions.

Kaliumklorid B. Braun is used to address electrolyte disturbances, particularly low potassium levels, in various clinical settings. - Hypokalemia: restores serum potassium to normal range, supporting cardiac and muscular function. - Potassium replacement therapy: provides controlled potassium infusion for patients undergoing diuretic treatment or postoperative care. - Electrolyte imbalance during renal replacement therapy: helps maintain potassium balance in dialysis patients.

Potassium chloride infusion can be associated with several adverse reactions, ranging from mild to serious. Common Side Effects: - Infusion site pain or irritation: discomfort at the catheter insertion point. - Nausea or vomiting: gastrointestinal upset following administration. - Mild hyperkalemia: transient elevation of serum potassium above normal. Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Severe hyperkalemia: marked increase in serum potassium leading to cardiac arrest. - Anaphylactic reaction: rare hypersensitivity with respiratory compromise.

When using Kaliumklorid B. Braun, several precautions should be observed to ensure patient safety and product integrity. - Serum potassium assessment: verify baseline potassium levels before infusion. - Cardiac monitoring: observe ECG for arrhythmias during and after administration. - Renal function evaluation: adjust dose in patients with impaired kidney function. - Infusion rate control: avoid rapid administration exceeding recommended mEq per hour. - Concomitant drug review: caution with other potassium‑increasing agents. - Store at room temperature: keep in original packaging, protect from moisture and light.

Potassium chloride may interact with other medicines, affecting potassium balance or cardiac function. Major Interactions (Avoid): - ACE inhibitors or ARBs: can cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia. - Trimethoprim‑containing antibiotics: potentiate potassium retention. Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hyperkalemia‑induced arrhythmias. - Digoxin: elevated potassium can alter digoxin toxicity risk.